Clinico-Microbiologic Profile and Treatment Outcomes of Patients with Infective Endocarditis Admitted in a Tertiary Pediatric Hospital from 2016 to 2025

Background: Infective Endocarditis (IE) is an infection of the heart’s endocardium, valves, and related structures, associated with significant morbidity and mortality in pediatric patients. It often follows bacteremia and is increasingly linked to congenital heart disease, post-procedural infections, and device use, with many cases requiring surgery. Understanding evolving clinical, microbiologic, and treatment patterns is essential for timely diagnosis and improved outcomes.

Objective: This study aimed to describe the clinical profile, microbiologic findings, management, and treatment outcomes of pediatric IE patients admitted to the Philippine Children’s Medical Center (PCMC) from 2016 to 2025.

Methods: A retrospective chart review included patients aged 0–18 years diagnosed with IE using the Modified Duke Criteria, excluding those with incomplete records or transferred cases. Data on demographics, clinical features, diagnostic findings, management, and outcomes were analyzed.

Results: Thirty-one pediatric patients were included, predominantly aged 7–12 years, male (68%), and from urban areas (55%). Fever (48%) and dyspnea (23%) were common, with tachycardia and cardiac murmurs in 94%. Prior procedures were reported in 45%, half involving central lines. Laboratory findings included elevated ESR (89%) and CRP (94%), anemia (74%), and leukocytosis (61%). Follow-up echocardiography showed reduced vegetation size in 75%. Blood cultures were positive in 61%, most commonly Staphylococcus (22%), fungal or gram-negative organisms (22%), and Streptococci (19%), with 32% beta-lactam sensitive. Combination antibiotics were used in 84%, predominantly beta-lactams (44%). Most patients were managed medically (87%), while 13% required surgery. Overall, 81% had favorable outcomes, and mortality was 19%.

Conclusion: This nine-year review highlights evolving epidemiology and microbiology of pediatric IE in a Philippine tertiary center, with increasing non-cardiac risk factors and a heterogeneous pathogen spectrum. Despite advances, morbidity and mortality remain substantial, emphasizing early diagnosis, individualized therapy, and strict infection control to improve outcomes in high-risk pediatric populations.